Warning Letters for Companies selling CBD containing Food and Beverages

Recommendation
12/13 November 2025
How to implement EU-GMP Chapter 8
The U.S. FDA warns five companies for illegally selling food and beverage products containing cannabidiol (CBD).
According to the FDA, the companies are selling CBD products that people may confuse for traditional foods or beverages which may result in unintentional consumption or overconsumption of CBD. "CBD-containing products in forms that are appealing to children, such as gummies, hard candies and cookies, are especially concerning", the agency says. The FDA previously issued several Warning Letters to companies illegally selling CBD containing products.
According to the agency, the use of CBD raises safety concerns, especially with long-term use. "The FDA has not found adequate information showing how much CBD can be consumed, and for how long, before causing harm. This is particularly true for vulnerable populations like children and those who are pregnant."
In addition, FDA experts commented on the agency’s concerns with adding CBD to food and on information they want consumers to know.
More information is available in FDA Warns Companies for Illegally Selling Food and Beverage Products that Contain CBD published on the agency´s website.
Related GMP News
04.03.2025FDA requests Information on the Use of Cannabis Products in Animals
04.03.2025How to Classify Borderline Products?
30.01.2025FDA seeks Feedback on Opiate Alkaloid Content of Poppy Seeds
30.01.2025Ensuring Microbiological Quality of Herbal Products
30.01.2025Research with Recreational Cannabis in Germany - Which Agency is Responsible?
15.10.2024Real-World Data Requirements for Herbal Medicinal Products